| Date Filed | Type | Description |
| 08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
4
| Berkenblit Anna (SVP & CHIEF MEDICAL OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 3,264 shares
@ $4.05, valued at
$13.2k
|
|
| 02/07/2023 |
4
| Berkenblit Anna (SVP & CHIEF MEDICAL OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 42,700 restricted stock units
@ $0
Granted 256,300 options to buy
@ $4.66, valued at
$1.2M
Granted 63,400 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Berkenblit Anna (SVP & CHIEF MEDICAL OFFICER) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 436 shares
@ $3.92, valued at
$1.7k
|
|
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Berkenblit Anna (Director) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Granted 20,000 options to buy
@ $2.79, valued at
$55.8k
|
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Berkenblit Anna (SVP & Chief Medical Officer) has filed a Form 4 on ImmunoGen, Inc.|
Txns:
| Granted 1,761 shares
@ $5.6, valued at
$9.9k
|
|
| 08/16/2021 |
3
| Berkenblit Anna (Director) has filed a Form 3 on Surrozen, Inc./DE |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Berkenblit Anna (VP & Chief Medical Officer) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 5,230 shares
@ $1.84, valued at
$9.6k
|
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| Berkenblit Anna (VP & Chief Medical Officer) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 2,455 shares
@ $4.08, valued at
$10k
|
|
| 10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2018 |
4
| Berkenblit Anna (VP & Chief Medical Officer) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Sold 5,851 shares
@ $9.46, valued at
$55.4k
|
|
| 02/23/2018 |
4
| Berkenblit Anna (VP & Chief Medical Officer) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Sold 17,329 shares
@ $10.88, valued at
$188.5k
|
|
| 02/20/2018 |
4
| Berkenblit Anna (VP & Chief Medical Officer) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 175,000 options to buy
@ $10.65, valued at
$1.9M
|
|
| 09/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |